HHS Assails Merck's 'Misunderstandings' Of Drug Pricing Law
By Theresa Schliep · September 12, 2023, 8:22 PM EDT
Merck & Co. Inc.'s suit challenging the Inflation Reduction Act's Medicare drug price-negotiation program is teeming with "misunderstandings" of the law, the U.S. Department of Health and Human Services told a...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login